Delivering information about medication assisted treatment to individuals who misuse opioids through a mobile app: a pilot study.
J Public Health (Oxf)
; 42(1): 149-154, 2020 02 28.
Article
em En
| MEDLINE
| ID: mdl-30445639
ABSTRACT
BACKGROUND:
Digital therapeutic tools (e.g. mobile applications) can be accessible, low-cost interventions that counter misconceptions about medication assisted treatment (MAT) and/or improve deficits in MAT knowledge that are common barriers to treatment entry among individuals with opioid dependence. The purpose of this pilot study was to examine the preliminary effectiveness of a mobile application, 'uMAT-R', that includes health information about OUD recovery supported by science and MAT benefits.METHODS:
Twenty-six adult participants with OUD recruited via social media completed all modules and pre/post-assessments within uMAT-R. McNemar's test was used to compare interest in treatment before and after completing the app, and paired t tests were used to compare MAT attitude scores before and after completing the modules within uMAT-R.RESULTS:
Before viewing uMAT-R, 32% agreed/strongly agreed that they were interested in starting treatment to recover from opioid misuse, compared to 48% after completing uMAT-R. The average scores on the MAT attitudes scale and its Aid to Behavior Change subscale improved from before to after viewing uMAT-R. Among the participants, 88% felt that uMAT-R would be useful to consult when making decisions about recovery.CONCLUSIONS:
Our encouraging pilot findings support the use of uMAT-R to help address the current opioid epidemic.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Buprenorfina
/
Aplicativos Móveis
Tipo de estudo:
Prognostic_studies
Limite:
Adult
/
Humans
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article